These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30419062)

  • 21. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.
    Qu Y; Cheng B; Shao N; Jia Y; Song Q; Tan B; Wang J
    Aging (Albany NY); 2020 Mar; 12(6):4757-4777. PubMed ID: 32209727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
    Liu L; Ruiz J; O'Neill SS; Grant SC; Petty WJ; Yang M; Chen K; Topaloglu U; Pasche B; Zhang W
    Mol Cancer; 2018 Apr; 17(1):81. PubMed ID: 29650000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma.
    Liu K; Kang M; Liao X; Wang R
    PLoS One; 2019; 14(7):e0219467. PubMed ID: 31323040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X; Chen L; Zhang T
    Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
    Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
    Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
    Yu J; Hu Y; Xu Y; Wang J; Kuang J; Zhang W; Shao J; Guo D; Wang Y
    BMC Cancer; 2019 Mar; 19(1):263. PubMed ID: 30902072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
    Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
    J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
    Li H; Tong L; Tao H; Liu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Novel CD74-NRG2α Fusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers.
    Kohsaka S; Hayashi T; Nagano M; Ueno T; Kojima S; Kawazu M; Shiraishi Y; Kishikawa S; Suehara Y; Takahashi F; Takahashi K; Suzuki K; Takamochi K; Mano H
    J Thorac Oncol; 2020 Jun; 15(6):948-961. PubMed ID: 32036070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
    Li C; Long Q; Zhang D; Li J; Zhang X
    BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive Analysis and Reinforcement Learning of Hypoxic Genes Based on Four Machine Learning Algorithms for Estimating the Immune Landscape, Clinical Outcomes, and Therapeutic Implications in Patients With Lung Adenocarcinoma.
    Sun Z; Zeng Y; Yuan T; Chen X; Wang H; Ma X
    Front Immunol; 2022; 13():906889. PubMed ID: 35757722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression levels and co‑targets of miRNA‑126‑3p and miRNA‑126‑5p in lung adenocarcinoma tissues: Αn exploration with RT‑qPCR, microarray and bioinformatic analyses.
    Chen P; Gu YY; Ma FC; He RQ; Li ZY; Zhai GQ; Lin X; Hu XH; Pan LJ; Chen G
    Oncol Rep; 2019 Feb; 41(2):939-953. PubMed ID: 30535503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
    Shi YX; Zhu T; Zou T; Zhuo W; Chen YX; Huang MS; Zheng W; Wang CJ; Li X; Mao XY; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2016 Dec; 7(51):85235-85243. PubMed ID: 27835911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDK1 serves as a potential prognostic biomarker and target for lung cancer.
    Li M; He F; Zhang Z; Xiang Z; Hu D
    J Int Med Res; 2020 Feb; 48(2):300060519897508. PubMed ID: 32020821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclassification of lung adenocarcinoma through comprehensive multi-omics data to benefit survival outcomes.
    Wei J; Wang X; Guo H; Zhang L; Shi Y; Wang X
    Comput Biol Chem; 2024 Oct; 112():108150. PubMed ID: 39018587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High
    Xie L; Dang Y; Guo J; Sun X; Xie T; Zhang L; Yan Z; Amin H; Guo X
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
    Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L
    Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.